WeVote
Log In

Bill

Bill

H 401

An act relating to exemptions for food manufacturing establishments

2025-2026 Regular Session Introduced by Ashley Bartley and 32 co-sponsors

Idaho creates a regulated medical cannabis program allowing qualifying patients 21+ to use cannabis with practitioner-approved cards, while prohibiting in-state production and publ

House message: Governor approved bill on June 2, 2025
0
WeVote Research Nonpartisan
Bill Summary · H 401

Bill Summary — H 401 (Sergeant Kitzhaber Medical Cannabis Act)

Note: The packet provided includes mixed materials (including an unrelated Massachusetts docket). This summary focuses on the Idaho statutory text and fiscal note titled the “Sergeant Kitzhaber Medical Cannabis Act,” which is the substantive content of H 401.

Purpose / Intent

The bill establishes a regulated medical cannabis program in Idaho. Its stated intent is to authorize possession, transportation, and use of cannabis and cannabis products for medical treatment of specified serious conditions, while creating a regulatory framework (patient and caregiver cards, verification, packaging and dosing rules, practitioner registration, and enforcement) and amending the state controlled‑substances schedules.

Key provisions

  • Adds Chapter 96 to Title 39, Idaho Code: creates the “Sergeant Kitzhaber Medical Cannabis Act.”
  • Reschedules cannabis: removes marijuana from Schedule I and places it in Schedule II under Idaho’s Uniform Controlled Substances Act (amendments to sections 37-2705 and 37-2707).
  • Qualifying patients:
    • Adults 21+ with specified diagnoses (examples listed in fiscal note: cancer, ALS, AIDS, wasting syndrome, Crohn’s disease, epilepsy, multiple sclerosis, debilitating seizures, terminal illness) may obtain a medical cannabis patient card after a recommendation from a “qualifying medical practitioner.”
    • Medical cannabis cards are valid for the period recommended by the practitioner, up to 1 year; renewable thereafter.
  • Qualifying practitioners: those authorized to prescribe Schedule II controlled substances in Idaho must register and provide treatment recommendations; rules for training and registration are provided.
  • Product forms, dosing, and packaging:
    • Defines medicinal dosage forms (liquid processed, solid processed, and unprocessed categories).
    • Requires measured dosage packaging with clear THC/CBD content; blister or tamper‑evident packaging is mandated for single doses.
    • If authorized by a practitioner, a cardholder may possess up to 30 grams of unprocessed cannabis flower (limit: ≤22% THC).
    • Smoking in public or in public view is prohibited.
  • Caregivers: establishment of designated caregiver registration, caregiver cards, and criminal history/background checks.
  • Electronic verification system: department‑run system linking issued cards for verification by law enforcement and others.
  • Enforcement and penalties:
    • Selling/providing medical cannabis to non‑cardholders remains a criminal offense; conviction triggers permanent revocation of the card by the Department of Health and Welfare.
    • Many activities are explicitly prohibited (e.g., in‑state production, sale, or growing of cannabis is not permitted under this bill).
  • Other provisions: limitations on liabilities/standard of care, nondiscrimination language, clarifications that insurers are not required to cover medical cannabis, importation/transportation rules, rulemaking authority, reporting requirements, and a severability clause.
  • Emergency clause: the act declares an emergency (intended to take effect immediately upon enactment).

Who is affected

  • Patients (Idaho residents age 21+) with qualifying conditions and their designated caregivers.
  • Medical practitioners authorized to prescribe Schedule II substances.
  • Department of Health and Welfare (program administration, card issuance, revocations).
  • Licensed medical cannabis pharmacists (new role defined) and entities interacting with the verification system.
  • Law enforcement (modified enforcement and verification responsibilities).
  • Insurers and employers (statutory clarifications on coverage and nondiscrimination).

Fiscal and procedural notes

  • Fiscal note (prepared by a proponent) states: no increase or decrease in revenue and no additional state/local expenditures; therefore, no fiscal impact.
  • Bill amendments: also amend multiple Idaho code sections (37-2732; 37-2732B; 25-2703) and grant rulemaking/training authority.
  • Timeline/status from materials: introduced March 12, 2025; Governor approved/signed June 2, 2025; emergency clause declared (immediate effect per statute).

Notable limits and open questions

  • The bill does not allow in‑state production, sale, or cultivation—medical access relies on permitted importation/transport mechanisms and specified product forms.
  • Program funding, practical mechanisms for lawful product supply/transport into Idaho, and federal law conflicts (federal prohibition) are not resolved by the text and may raise implementation questions.
  • The fiscal note was prepared by a proponent and includes a disclaimer that it is not an official expression of legislative intent.

If you want, I can prepare a one‑page checklist of implementation tasks the Department would need to adopt rules and operationalize the program (verification system, card issuance, practitioner registration, import protocols).

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.